tailieunhanh - Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with rising incidence and with 5- years overall survival of less than 8%. PDAC creates an immune-suppressive tumor microenvironment to escape immune-mediated eradication. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN